Publications found:
68,755
Sort by:
Interleukin-18 (IL-18) Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... Business Days. CmaxInsight’s, “Interleukin-18 (IL-18) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Interleukin-18 (IL-18) Inhibitor. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Interleukin-2 (IL-2) Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... Business Days. CmaxInsight’s, “Interleukin-2 (IL-2) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... client to understand the landscape of the Interleukin-2 (IL-2) Inhibitor. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Interleukin-23 (IL-23) Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... Business Days. CmaxInsight’s, “Interleukin-23 (IL-23) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Interleukin-23 (IL-23) Inhibitor. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Interleukin-4 (IL-4) Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... Business Days. CmaxInsight’s, “Interleukin-4 (IL-4) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... client to understand the landscape of the Interleukin-4 (IL-4) Inhibitor. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Interleukin-5 (IL-5) Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... Business Days. CmaxInsight’s, “Interleukin-5 (IL-5) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... client to understand the landscape of the Interleukin-5 (IL-5) Inhibitor. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Interleukin-8 (IL-8) Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... Business Days. CmaxInsight’s, “Interleukin-8 (IL-8) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... client to understand the landscape of the Interleukin-8 (IL-8) Inhibitor. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Janus Kinase (JAK) Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... Business Days. CmaxInsight’s, “Janus Kinase (JAK) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Janus Kinase (JAK) Inhibitor. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Janus Kinase 1 (JAK1) Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... the clients within 1-2 Business Days. CmaxInsight’s, “Janus Kinase 1 (JAK1) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Janus Kinase 1 (JAK1) Inhibitor R&D Please note: Certain sections in the report ...
December 2018
60 pages
Janus Kinase 3 (JAK3) Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... the clients within 1-2 Business Days. CmaxInsight’s, “Janus Kinase 3 (JAK3) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Janus Kinase 3 (JAK3) Inhibitor R&D Please note: Certain sections in the report ...
December 2018
60 pages
Kainate Receptor Antagonist -Pipeline Intelligence, 2019
US$ 1,000.00
... 1-2 Business Days. CmaxInsight’s, “Kainate Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Kainate Receptor Antagonist. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Kallikrein Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... within 1-2 Business Days. CmaxInsight’s, “Kallikrein Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the Kallikrein Inhibitor. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Kappa Antagonist -Pipeline Intelligence, 2019
US$ 1,000.00
... within 1-2 Business Days. CmaxInsight’s, “Kappa Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Kappa Antagonist. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Kv1.3/1.5 Potassium Channel Blockers -Pipeline Intelligence, 2019
US$ 1,000.00
... Days. CmaxInsight’s, “Kv1.3/1.5 Potassium Channel Blockers-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Kv1.3/1.5 Potassium Channel Blockers. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Kv1.3 Potassium Channel Blockers -Pipeline Intelligence, 2019
US$ 1,000.00
... Days. CmaxInsight’s, “Kv1.3 Potassium Channel Blockers-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Kv1.3 Potassium Channel Blockers. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
LAG-3 Antagonist -Pipeline Intelligence, 2019
US$ 1,000.00
... within 1-2 Business Days. CmaxInsight’s, “LAG-3 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the LAG-3 Antagonist. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... clients within 1-2 Business Days. CmaxInsight’s, “Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor R&D Please note: Certain sections in the ...
December 2018
60 pages
Leukotriene Antagonist -Pipeline Intelligence, 2019
US$ 1,000.00
... within 1-2 Business Days. CmaxInsight’s, “Leukotriene Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... client to understand the landscape of the Leukotriene Antagonist. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Leukotriene D4 Antagonist -Pipeline Intelligence, 2019
US$ 1,000.00
... 1-2 Business Days. CmaxInsight’s, “Leukotriene D4 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Leukotriene D4 Antagonist. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... the clients within 1-2 Business Days. CmaxInsight’s, “Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitor -Pipeline Intelligence, 2019”, report provides ... identifying potential partners with progressing projects for Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitor to enhance and expand ...
December 2018
60 pages
Lysine Specific Demethylase 1 (LSD-1) Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... the clients within 1-2 Business Days. CmaxInsight’s, “Lysine Specific Demethylase 1 (LSD-1) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Lysine Specific Demethylase 1 (LSD-1) Inhibitor to enhance and expand business ...
December 2018
60 pages
Matrix Metalloproteinase 9 (MMP-9) Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... clients within 1-2 Business Days. CmaxInsight’s, “Matrix Metalloproteinase 9 (MMP-9) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... companies Assess challenges and opportunities that influence Matrix Metalloproteinase 9 (MMP-9) Inhibitor R&D Please note: Certain sections in the ...
December 2018
60 pages
Melanocortin 4 Receptor (MC4R) Agonist -Pipeline Intelligence, 2019
US$ 1,000.00
... clients within 1-2 Business Days. CmaxInsight’s, “Melanocortin 4 Receptor (MC4R) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Melanocortin 4 Receptor (MC4R) Agonist R&D Please note: Certain sections in the ...
December 2018
60 pages
Methionine Aminopeptidase 2 (Metap2) Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... within 1-2 Business Days. CmaxInsight’s, “Methionine Aminopeptidase 2 (Metap2) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Methionine Aminopeptidase 2 (Metap2) Inhibitor R&D Please note: Certain sections in the ...
December 2018
60 pages
mGlu 2/3 Agonist -Pipeline Intelligence, 2019
US$ 1,000.00
... 1-2 Business Days. CmaxInsight’s, “mGlu 2/3 Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the mGlu 2/3 Agonist. Pipeline Covered: This section mentions all the promising therapies ...
December 2018
60 pages
mGlu 2/3/5 Antagonist -Pipeline Intelligence, 2019
US$ 1,000.00
... 1-2 Business Days. CmaxInsight’s, “mGlu 2/3/5 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the mGlu 2/3/5 Antagonist. Pipeline Covered: This section mentions all the promising therapies ...
December 2018
60 pages
mGlu5 Antagonist -Pipeline Intelligence, 2019
US$ 1,000.00
... within 1-2 Business Days. CmaxInsight’s, “mGlu5 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the mGlu5 Antagonist. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Monoamine Oxidase Inhibitor (MAOIs) -Pipeline Intelligence, 2019
US$ 1,000.00
... Days. CmaxInsight’s, “Monoamine Oxidase Inhibitor (MAOIs)-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Monoamine Oxidase Inhibitor (MAOIs). Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Monoamine Oxidase B (MAO-B) Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... clients within 1-2 Business Days. CmaxInsight’s, “Monoamine Oxidase B (MAO-B) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Monoamine Oxidase B (MAO-B) Inhibitor R&D Please note: Certain sections in the ...
December 2018
60 pages
mTORC-1 Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... within 1-2 Business Days. CmaxInsight’s, “mTORC-1 Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the mTORC-1 Inhibitor. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
mTORC-2 Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... within 1-2 Business Days. CmaxInsight’s, “mTORC-2 Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the mTORC-2 Inhibitor. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Mu Antagonist -Pipeline Intelligence, 2019
US$ 1,000.00
... within 1-2 Business Days. CmaxInsight’s, “Mu Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA ... the client to understand the landscape of the Mu Antagonist. Pipeline Covered: This section mentions all the promising therapies ...
December 2018
60 pages
Murine Double Minute 2 (MDM2) Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... the clients within 1-2 Business Days. CmaxInsight’s, “Murine Double Minute 2 (MDM2) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Murine Double Minute 2 (MDM2) Inhibitor to enhance and expand business potential ...
December 2018
60 pages
Muscarinic Acetylcholine Receptor (mAChR) Antagonist -Pipeline Intelligence, 2019
US$ 1,000.00
... within 1-2 Business Days. CmaxInsight’s, “Muscarinic Acetylcholine Receptor (mAChR) Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Muscarinic Acetylcholine Receptor (mAChR) Antagonist R&D Please note: Certain sections in ...
December 2018
60 pages
Muscarinic Acetylcholine Receptor M2 Antagonist -Pipeline Intelligence, 2019
US$ 1,000.00
... within 1-2 Business Days. CmaxInsight’s, “Muscarinic Acetylcholine Receptor M2 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Muscarinic Acetylcholine Receptor M2 Antagonist R&D Please note: Certain sections in the ...
December 2018
60 pages
Muscarinic Acetylcholine Receptor M3 Antagonist -Pipeline Intelligence, 2019
US$ 1,000.00
... within 1-2 Business Days. CmaxInsight’s, “Muscarinic Acetylcholine Receptor M3 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Muscarinic Acetylcholine Receptor M3 Antagonist R&D Please note: Certain sections in the ...
December 2018
60 pages
Muscarinic Agonist -Pipeline Intelligence, 2019
US$ 1,000.00
... within 1-2 Business Days. CmaxInsight’s, “Muscarinic Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Muscarinic Agonist. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Muscarinic M1 Agonist -Pipeline Intelligence, 2019
US$ 1,000.00
... 1-2 Business Days. CmaxInsight’s, “Muscarinic M1 Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Muscarinic M1 Agonist. Pipeline Covered: This section mentions all the promising therapies ...
December 2018
60 pages
Myostatin Inhibitor -Pipeline Intelligence, 2019
US$ 1,000.00
... within 1-2 Business Days. CmaxInsight’s, “Myostatin Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Myostatin Inhibitor. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Neurokinin (NK) Receptor Antagonist -Pipeline Intelligence, 2019
US$ 1,000.00
... Days. CmaxInsight’s, “Neurokinin (NK) Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Neurokinin (NK) Receptor Antagonist. Pipeline Covered: This section mentions all the promising ...
December 2018
60 pages
Neurokinin 1 (NK1) Receptor Agonist -Pipeline Intelligence, 2019
US$ 1,000.00
... clients within 1-2 Business Days. CmaxInsight’s, “Neurokinin 1 (NK1) Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Neurokinin 1 (NK1) Receptor Agonist R&D Please note: Certain sections in the ...
December 2018
60 pages
